Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Expensify (EXFY) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Expensify (EXFY) over the last 6 years, with Q3 2025 value amounting to $6.7 million.

  • Expensify's Share-based Compensation fell 1267.37% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.6 million, marking a year-over-year decrease of 747.91%. This contributed to the annual value of $33.5 million for FY2024, which is 1862.32% down from last year.
  • According to the latest figures from Q3 2025, Expensify's Share-based Compensation is $6.7 million, which was down 1267.37% from $6.9 million recorded in Q2 2025.
  • Expensify's Share-based Compensation's 5-year high stood at $14.7 million during Q1 2022, with a 5-year trough of $710000.0 in Q1 2021.
  • In the last 5 years, Expensify's Share-based Compensation had a median value of $10.0 million in 2024 and averaged $8.6 million.
  • Per our database at Business Quant, Expensify's Share-based Compensation soared by 196577.46% in 2022 and then tumbled by 3179.25% in 2023.
  • Over the past 5 years, Expensify's Share-based Compensation (Quarter) stood at $12.1 million in 2021, then fell by 12.75% to $10.5 million in 2022, then rose by 0.58% to $10.6 million in 2023, then dropped by 5.64% to $10.0 million in 2024, then tumbled by 33.38% to $6.7 million in 2025.
  • Its Share-based Compensation was $6.7 million in Q3 2025, compared to $6.9 million in Q2 2025 and $8.0 million in Q1 2025.